Related content

Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature

By Pinto Evelin   Pinelo Sueli   Osório Marta   Ferreira Carla   Serra Helena   Pires Ilda   Barbosa António   Figueiredo Helena   Felgueira Eduarda   Tavares Angelina  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 545-548

Informa Healthcare

Access to resources Recommend Favorite

Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.

By Cheung A P   Lu J K   Chang R J  

Human Reproduction, Vol. 12, Iss. 6, 1997-06 ,pp. : 1156-1164

Oxford University Press

Access to resources Recommend Favorite

Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?

By Lin Y  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 885-888

Oxford University Press

Access to resources Recommend Favorite

Effect of gonadotropin-releasing hormone antagonists on intrauterine insemination cycles in women with polycystic ovary syndrome: a meta-analysis

By Luo Shan   Li Shangwei   Li Xiaohong   Bai Yu   Jin Song  

Gynecological Endocrinology, Vol. 30, Iss. 4, 2014-04 ,pp. : 255-259

Informa Healthcare

Access to resources Recommend Favorite

Influence of gonadotrophin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization

By Alvarez C.   Cremades N.   Blasco N.   Bernabeu R.  

Human Reproduction, Vol. 12, Iss. 11, 1997-11 ,pp. : 2366-2369

Oxford University Press

Access to resources Recommend Favorite